La Jolla Pharmaceutical Company announced that its Board of Directors has appointed Larry Edwards as President. From 2015 to 2020, Mr. Edwards served in various positions at Tetraphase Pharmaceuticals Inc., most recently serving as Chief Executive Officer. From 2014 to 2015, he served as Senior Director of Marketing of the Gram-negative Franchise of Cubist Pharmaceuticals Inc. (acquired by Merck & Co. Inc.). From 1999 to 2014, Mr. Edwards served in various positions at Merck and Co. Inc., most recently serving as Global Marketing Director of Clostridium Difficile and New Infectious Disease Products. Mr. Edwards received a B.S. degree in business and healthcare administration from Ohio University.